Abstract:Objective To study the clinical features of post-renal transplantation diabetes mellitus(PTDM) and improve its prevention and treatment.Methods Twenty-eight patients with PTDM were retrospectively reviewed.The general condition,blood glucose,glycosylated hemoglobin(HbA1c),blood cyclosporine A trough level(CsA Co),serum lipid,islet function and islet antibodies were detected and the results were compared with those of 30 patients with type 2 diabetes mellitus(T2DM) and matched DM duration.Results ① The renal transplantation history,median of PTDM history and median interval from transplantation to onset of PTDM were(5.5±4.7) years,0.8 years(2 d-7 years) and 2.3 years( years),respectively.Ten cases had the diabetic symptoms while 14 cases had family history of DM.② Compared with T2DM patients with matched diabetic duration,patients of PTDM had higher incidence of hypertension(82.1% vs.53.3%,P=0.019).PTDM patients had earlier onset than T2DM patients( years vs. years,P=0.001).The total cholesterol([5.57±1.53] vs.[4.45±1.18] mmo/L,P=0.003),triglyceride([2.51±1.55] vs.[1.82±0.68] mmo/L,P=0.037),apolipoprotein E([67.72±18.24] vs.[50.68±11.61] mg/L,P=0.001) and high-density lipoprotein cholesterol([1.33±0.46] vs.[0.93±0.28] mmo/L,P=0.02) in PTDM patients were significantly higher than those in the T2MD patients.Postprandial C-peptide was lower([1 394.96±835.81] vs.[2 399.71±1 513.56] pmol/L,P=0.004).More patients of PTDM had DM family history(50% vs.20%,P=0.016) and received insulin therapy(67.86% vs.36.67%,P=0.018).There were no significant difference in body mass index(BMI),apolipoprotein AI,apolipoprotein B,lipoprotein a,low-density lipoprotein cholesterol and fasting C-peptide between the 2 groups.③ Positive islet antibodies were found in 2 PTDM patients.④ There was no correlation between fasting blood glucose and CsA Co,either was HbA1c(both P>0.05).Conclusion PTDM is a serious complication secondary to post-renal transplantation immuno-suppression.Compared with T2DM,patients of PTDM are often asymptomatic and have earlier onset with impaired islet function.PTDM patients have severe dyslipidemia.Blood glucose and serum lipid should be carefully monitored after kidney transplantation.Earlier PTDM diagnosis and appropriate treatment are beneficial to reverse glucose and lipid disorder.

Diagnoses and Treatments of Posttransplant Diabetes Mellitus

Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes

Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: the impact of pre-existing diabetes mellitus.

Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes

Clinical features of post-renal transplantation diabetes mellitus:an analysis of 28 cases

Managing Post-Transplant Diabetes Mellitus after Kidney Transplantation: Challenges and Advances in Treatment

Genetic and Epigenetic Associations with Post-Transplant Diabetes Mellitus

Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention

Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia

Post-Transplant Diabetes Mellitus in Liver Transplantation: Hangzhou Experience

An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management

Impact of varied immunosuppressive agents and posttransplant diabetes mellitus on prognosis among diverse transplant recipients (Experimental studies)

The Effect of Posttransplantation Diabetes Mellitus on the Prognosis of Transplantation: a Prospective Cohort Study

Study on risk factors for new onset diabetes mellitus post orthotopic heart transplant (PTDM) and the relationship between PTDM and long-term survival

Clinical study of surviving in simultaneous pancreas-kidney transplantation

Diabetic Kidney Disease in Post-Kidney Transplant Patients

Simultaneous pancreas-kidney transplantation: a report of 5 cases

An Analysis on the Prevalence and Risk Factors of Post-Transplant Diabetes Mellitus after Renal Transplantation

Role of leptin and adiponectin in the pathogenesis of post-transplant diabetes mellitus

Insight Into the Metabolomic Characteristics of Post-Transplant Diabetes Mellitus by the Integrated LC-MS and GC-MS Approach- Preliminary Study

Analysis of risk factors for post-transplant diabetes mellitus in patients with renal transplants